Currently, there are 203.83M common shares owned by the public and among those 182.74M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -6.22% and -19.48% over the past three months. WEN shares are trading -8.47% year to date (YTD), with the 12-month market performance down to -17.61% lower. It has a 12-month low price of $13.72 and touched a high of $20.65 over the same period. WEN has an average intraday trading volume of 4.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.73%, -2.24%, and -12.35% respectively.
Institutional ownership of Wendy’s Co (NASDAQ: WEN) shares accounts for 85.64% of the company’s 203.83M shares outstanding.
It has a market capitalization of $2.99B and a beta (3y monthly) value of 0.61. The stock’s trailing 12-month PE ratio is 15.78, while the earnings-per-share (ttm) stands at $0.95. The company has a PEG of 2.24 and a Quick Ratio of 1.83 with the debt-to-equity ratio at 15.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.86% over the week and 3.20% over the month.
Earnings per share for the fiscal year are expected to increase by 0.59%, and 11.19% over the next financial year. EPS should shrink at an annualized rate of 7.04% over the next five years, compared to 12.83% over the past 5-year period.
Looking at the support for the WEN, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on February 26, 2025, with the firm’s price target at $20-$17. Morgan Stanley coverage for the Wendy’s Co (WEN) stock in a research note released on January 21, 2025 offered a Underweight rating with a price target of $14. Goldman was of a view on June 13, 2024 that the stock is Sell, while Stephens gave the stock Equal-Weight rating on April 12, 2024, issuing a price target of $20. Bernstein on their part issued Mkt Perform rating on February 22, 2024.
